HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yong-Beom Park Selected Research

Antineutrophil Cytoplasmic Antibodies (ANCA)

11/2022Clinical impact of proteinase 3-antineutrophil cytoplasmic antibody positivity in eosinophilic granulomatosis with polyangiitis.
11/2022Rheumatoid factor positivity in antineutrophil cytoplasmic antibody-associated vasculitis: a distinct clinical entity or innocent bystander?
10/2022Unclassifiable repeated antineutrophil cytoplasmic antibody (ANCA) positivity in diseases other than ANCA-associated vasculitis.
7/2022Predicting the depressive status using empirical dietary inflammatory index in patients with antineutrophil cytoplasmic antibody-associated vasculitis.
6/2022Birmingham vasculitis activity score and the short form 36-item health survey predict current depressive disorders in patients with antineutrophil cytoplasmic antibody-associated vasculitis during the SARS-CoV-2 pandemic.
6/2022Triglyceride and Glucose Index Predicts Acute Coronary Syndrome in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
5/2022Application of the 2022 ACR/EULAR criteria for microscopic polyangiitis to patients with previously diagnosed microscopic polyangiitis.
5/2022Reclassification of previously diagnosed GPA patients using the 2022 ACR/EULAR classification criteria.
5/2022Effect of numbers of metabolic syndrome components on mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis with metabolic syndrome.
5/2022New body mass index for predicting prognosis in patients with antineutrophil cytoplasmic antibody-associated vasculitis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yong-Beom Park Research Topics

Disease

62Vasculitis (Vasculitides)
11/2022 - 03/2017
46Rheumatoid Arthritis
08/2022 - 08/2002
45Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
10/2022 - 03/2017
14Chronic Kidney Failure (Chronic Renal Failure)
11/2022 - 03/2018
14Systemic Lupus Erythematosus (Libman-Sacks Disease)
05/2022 - 07/2010
14Inflammation (Inflammations)
01/2022 - 12/2012
12Autoimmune Diseases (Autoimmune Disease)
10/2022 - 02/2012
11Infections
10/2022 - 10/2006
10Pain (Aches)
06/2022 - 07/2014
10Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
05/2022 - 11/2012
9Microscopic Polyangiitis
01/2022 - 03/2017
9Ankylosing Spondylitis
01/2021 - 04/2007
8Knee Osteoarthritis
01/2021 - 04/2016
6Arthritis (Polyarthritis)
04/2022 - 03/2009
6Liver Cirrhosis (Hepatic Cirrhosis)
01/2020 - 10/2012
5Churg-Strauss Syndrome (Allergic Angiitis)
11/2022 - 08/2018
5Proteinuria
07/2020 - 12/2012
5Experimental Arthritis
01/2020 - 03/2009
5Neoplasms (Cancer)
11/2019 - 08/2006
4Interstitial Lung Diseases (Interstitial Lung Disease)
10/2022 - 07/2020
4Fever (Fevers)
04/2022 - 01/2017
4Stroke (Strokes)
01/2022 - 08/2020
4Liver Diseases (Liver Disease)
01/2022 - 10/2012
4Systemic Scleroderma (Systemic Sclerosis)
12/2021 - 07/2015
4Lupus Nephritis
07/2020 - 07/2013
4Nephritis
11/2019 - 12/2012
4Osteoarthritis
10/2019 - 04/2016
3Metabolic Syndrome (Dysmetabolic Syndrome X)
05/2022 - 12/2021
3Tuberculosis (Tuberculoses)
01/2022 - 05/2012
3Fibrosis (Cirrhosis)
04/2021 - 03/2019
3Immunoglobulin G4-Related Disease
10/2020 - 08/2017
3Takayasu Arteritis (Arteritis, Takayasu's)
10/2020 - 07/2010
3Chronic Disease (Chronic Diseases)
08/2020 - 01/2009
3Diabetes Mellitus
01/2020 - 09/2017
2Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
11/2022 - 08/2019
2Depressive Disorder (Melancholia)
06/2022 - 12/2019
2Fatigue
06/2022 - 09/2012
2Granuloma
05/2022 - 01/2019
2Hypertension (High Blood Pressure)
05/2022 - 06/2019
2Dermatomyositis (Dermatopolymyositis)
04/2022 - 07/2010
2Latent Tuberculosis
01/2022 - 03/2014
2Metabolic Bone Diseases (Osteopenia)
12/2021 - 02/2017
2Osteoporosis
12/2021 - 08/2020
2Glomerulonephritis
01/2021 - 07/2020

Drug/Important Bio-Agent (IBA)

78Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
11/2022 - 03/2017
20Pharmaceutical PreparationsIBA
03/2022 - 01/2015
13Biomarkers (Surrogate Marker)IBA
05/2022 - 09/2014
12Methotrexate (Mexate)FDA LinkGeneric
08/2021 - 02/2012
11CytokinesIBA
09/2021 - 03/2009
9C-Reactive ProteinIBA
02/2022 - 04/2007
9Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 11/2009
8Tumor Necrosis Factor InhibitorsIBA
08/2022 - 03/2014
7Peroxidase (Myeloperoxidase)IBA
05/2022 - 03/2017
6Myeloblastin (Proteinase 3)IBA
11/2022 - 03/2017
6CreatinineIBA
03/2022 - 01/2020
6Serum AlbuminIBA
03/2022 - 07/2016
6Proteins (Proteins, Gene)FDA Link
01/2022 - 03/2014
6Biosimilar PharmaceuticalsIBA
01/2021 - 01/2017
6Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2020 - 01/2009
5Glucose (Dextrose)FDA LinkGeneric
06/2022 - 01/2017
5AlbuminsIBA
01/2022 - 01/2017
5Therapeutic UsesIBA
01/2021 - 03/2009
4Biological ProductsIBA
05/2022 - 05/2017
4GlucocorticoidsIBA
12/2021 - 09/2012
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
08/2021 - 03/2013
4Azathioprine (Imuran)FDA LinkGeneric
08/2021 - 03/2013
4Immunoglobulin G (IgG)IBA
04/2021 - 08/2017
4Immunosuppressive Agents (Immunosuppressants)IBA
01/2021 - 03/2013
4Antirheumatic Agents (DMARD)IBA
01/2021 - 08/2002
4Ferritins (Ferritin)IBA
11/2018 - 01/2009
3Antiphospholipid AntibodiesIBA
11/2022 - 07/2019
3Rheumatoid FactorIBA
11/2022 - 01/2017
3AutoantibodiesIBA
10/2022 - 03/2021
3insulin receptor-related receptor (IRR)IBA
01/2022 - 05/2019
3Acute-Phase Proteins (Acute-Phase Protein)IBA
01/2022 - 04/2007
3Interleukin-6 (Interleukin 6)IBA
01/2022 - 01/2011
3AdipokinesIBA
01/2021 - 01/2013
3Etanercept (Enbrel)FDA Link
01/2021 - 01/2017
3Adrenal Cortex Hormones (Corticosteroids)IBA
12/2020 - 08/2002
3Infliximab (Remicade)FDA Link
08/2020 - 02/2020
3CT-P13IBA
08/2020 - 02/2020
3Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA
11/2019 - 07/2018
3Alanine Transaminase (SGPT)IBA
05/2019 - 01/2009
3Hepatitis B Surface Antigens (HBsAg)FDA Link
08/2018 - 11/2009
3CollagenIBA
01/2018 - 10/2006
3Celecoxib (Celebrex)FDA Link
08/2016 - 01/2014
3Liver X ReceptorsIBA
05/2014 - 05/2010
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
11/2022 - 01/2021
2Peptide Hydrolases (Proteases)FDA Link
11/2022 - 07/2020
2Anti-Citrullinated Protein AntibodiesIBA
08/2022 - 07/2012
2HDL CholesterolIBA
05/2022 - 01/2020
2Rituximab (Mabthera)FDA Link
08/2021 - 01/2012
2LBEC0101IBA
01/2021 - 01/2019
2mizoribineIBA
01/2021 - 11/2019

Therapy/Procedure

23Therapeutics
02/2022 - 08/2002
7Knee Replacement Arthroplasty (Total Knee Replacement)
06/2022 - 05/2014
4Aftercare (After-Treatment)
01/2022 - 08/2017
3Injections
03/2022 - 01/2017
2Reoperation
01/2022 - 08/2017
2Biological Therapy
01/2022 - 05/2017